Copper Transport Disorders and Genetic Mechanisms

Copper is an essential trace element that functions as a cofactor for a range of vital enzymes involved in oxidative phosphorylation, connective tissue crosslinking and neurotransmitter synthesis. Tight regulation of copper uptake, intracellular distribution and excretion is achieved by specialised P-type ATPases, notably ATP7A and ATP7B, which shuttle between the trans-Golgi network and the plasma membrane in response to copper levels. Mutations in ATP7A give rise to a spectrum of disorders including Menkes disease—an X-linked neurodegenerative condition marked by severe copper deficiency in the brain—and occipital horn syndrome, characterised by connective tissue defects. Conversely, loss of ATP7B activity underlies Wilson disease, in which copper accumulation leads to hepatic and neurological injury. Pathogenic variants disrupt ATPase folding, trafficking or catalytic activity, perturbing cuproenzyme maturation and provoking multisystem pathology. Advances in molecular genetics, imaging and model organisms have clarified how genotype influences ATP7A/ATP7B localisation, copper bioavailability and clinical phenotype, driving the development of novel diagnostic biomarkers and targeted therapies such as early copper supplementation or gene correction strategies.

Research from Nature Portfolio

Recent studies have elucidated the relationship between mutant ATP7A trafficking and disease severity. Analyses of numerous missense variants revealed that mutations preventing ATP7A exit from the trans-Golgi network correlate with the most severe Menkes phenotypes, whereas those permitting partial copper-dependent redistribution yield milder outcomes. This work underscores the critical roles of phosphorylation for TGN export and dephosphorylation for recycling. A complementary report employed synchrotron-generated X-ray fluorescence imaging to map copper distribution in treated Menkes patients at subcellular resolution. These experiments demonstrated copper transit through spinal cord parenchyma, accumulation in renal tubular cells and intestinal mucosa, and highlighted routes of systemic copper clearance. Insights from this high-resolution imaging have informed assessments of standard copper-histidine therapy and suggested refinements to optimise tissue copper delivery.

Copper Transport Disorders and Genetic Mechanisms publication trend

The graph below shows the total number of articles in copper transport disorders and genetic mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

ATP7A: A copper-transporting P-type ATPase that delivers copper to enzymes in the secretory pathway and exports excess copper at the plasma membrane.

Trans-Golgi network (TGN): A subcellular compartment where copper-dependent enzymes acquire their metal cofactors and from which ATP7A/ATP7B traffic in response to copper levels.

Cuproenzymes: Enzymes that require copper as a catalytic cofactor for functions such as oxidative stress defence, connective tissue crosslinking and neurotransmitter synthesis.

Lysyl oxidase: A copper-dependent enzyme that catalyses crosslinking of collagen and elastin; its dysfunction contributes to connective tissue abnormalities in ATP7A disorders.

Occipital Horn Syndrome (OHS): A milder allelic variant of ATP7A deficiency featuring connective tissue manifestations such as occipital exostoses, cutis laxa and bladder diverticula.

References

1. Characterization of ATP7A missense mutants suggests a correlation between intracellular trafficking and severity of Menkes disease. Scientific Reports (2017).
2. Diagnostic copper imaging of Menkes disease by synchrotron radiation-generated X-ray fluorescence analysis. Scientific Reports (2016).
3. Defining the Clinical, Molecular and Ultrastructural Characteristics in Occipital Horn Syndrome: Two New Cases and Review of the Literature. Genes (2019).
4. Genetic Disorders Associated with Metal Metabolism. Cells (2019).
5. Mottled Mice and Non-Mammalian Models of Menkes Disease. Frontiers in Molecular Neuroscience (2015).